United States · FDA National Drug Code directory

Ring HP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
44911-0626_dfb88b6d-ce5b-4ee0-9fca-6a7946664679
Product NDC
44911-0626
Form
LIQUID
Composition / generic term
Ginkgo Biloba, Chininum Sulphuricum, Cinchona Officinalis, Graphites, Natrum Salicylicum, Plumbum Metallicum, Salicylicum acidum, Spigelia Anthelmia, Thiosinaminum
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20201221
Source listing expiry
20261231

Source-listed ingredients

  • GINKGO — 6 [hp_X]/mL
  • QUININE SULFATE — 30 [hp_X]/mL
  • CINCHONA OFFICINALIS BARK — 30 [hp_X]/mL
  • GRAPHITE — 30 [hp_X]/mL
  • SODIUM SALICYLATE — 30 [hp_X]/mL
  • LEAD — 30 [hp_X]/mL
  • SALICYLIC ACID — 30 [hp_X]/mL
  • SPIGELIA ANTHELMIA WHOLE — 30 [hp_X]/mL
  • ALLYLTHIOUREA — 30 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (44911-0626-1) · 44911-0626-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →